Connection
Holly Wyatt to Narcotic Antagonists
This is a "connection" page, showing publications Holly Wyatt has written about Narcotic Antagonists.
|
|
Connection Strength |
|
|
|
|
|
0.026 |
|
|
|
-
Apovian CM, Aronne L, Rubino D, Still C, Wyatt H, Burns C, Kim D, Dunayevich E. A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). Obesity (Silver Spring). 2013 May; 21(5):935-43.
Score: 0.026